ES2164097T3 - Uso de anestesicos topicos para la fabricacion de un medicamento para el tratamiento del asma bronquial. - Google Patents
Uso de anestesicos topicos para la fabricacion de un medicamento para el tratamiento del asma bronquial.Info
- Publication number
- ES2164097T3 ES2164097T3 ES94907887T ES94907887T ES2164097T3 ES 2164097 T3 ES2164097 T3 ES 2164097T3 ES 94907887 T ES94907887 T ES 94907887T ES 94907887 T ES94907887 T ES 94907887T ES 2164097 T3 ES2164097 T3 ES 2164097T3
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- bronchial asthma
- anesthetics
- topic
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Addiction (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE SUMINISTRA UN METODO TERAPEUTICO PARA TRATAR LAS ENFERMEDADES DE HIPERSENSIBILIDAD ASOCIADAS CON LOS EOSINOFILOS, TALES COMO EL ASMA BRONQUIAL, ADMINISTRANDO LOCALMENTE A UN MAMIFERO CON LA NECESIDAD DE DICHO TRATAMIENTO, UNA CANTIDAD EFECTIVA DE UN ANESTESICO TOPICO, TAL COMO LIDOCAINA, O UNA SAL FARMACOLOGICAMENTE ACEPTABLE DEL MISMO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/012,343 US5510339A (en) | 1993-02-02 | 1993-02-02 | Method for the treatment of bronchial asthma by administration of topical anesthetics |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2164097T3 true ES2164097T3 (es) | 2002-02-16 |
Family
ID=21754520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94907887T Expired - Lifetime ES2164097T3 (es) | 1993-02-02 | 1994-01-25 | Uso de anestesicos topicos para la fabricacion de un medicamento para el tratamiento del asma bronquial. |
Country Status (12)
Country | Link |
---|---|
US (2) | US5510339A (es) |
EP (1) | EP0682514B1 (es) |
JP (2) | JPH08505157A (es) |
AT (1) | ATE205389T1 (es) |
AU (1) | AU685777B2 (es) |
CA (1) | CA2155200C (es) |
DE (1) | DE69428268T2 (es) |
DK (1) | DK0682514T3 (es) |
ES (1) | ES2164097T3 (es) |
NZ (1) | NZ261990A (es) |
PT (1) | PT682514E (es) |
WO (1) | WO1994017790A1 (es) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5589156A (en) * | 1994-05-02 | 1996-12-31 | Henry; Richard A. | Prilocaine and hydrofluourocarbon aerosol preparations |
US5660835A (en) * | 1995-02-24 | 1997-08-26 | East Carolina University | Method of treating adenosine depletion |
US20020032160A1 (en) * | 1995-02-24 | 2002-03-14 | Nyce Jonathan W. | Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels |
US5928883A (en) * | 1996-11-13 | 1999-07-27 | Mayo Foundation For Medical Education | Eosinophil granole proteins as indicators of inflammatory bowel disorders |
US6071910A (en) * | 1996-12-05 | 2000-06-06 | Mayo Foundation For Medical Education And Research | Use of agents to treat eosinophil-associated pathologies |
US5837713A (en) * | 1997-02-26 | 1998-11-17 | Mayo Foundation For Medical Education And Research | Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids |
US5881720A (en) * | 1997-04-29 | 1999-03-16 | The Procter & Gamble Company | Method of delivering halotherapy |
ES2219905T3 (es) * | 1997-08-27 | 2004-12-01 | President And Fellows Of Harvard College | Composiciones para mejorar la curacion de las heridas. |
US6598603B1 (en) * | 1997-12-31 | 2003-07-29 | Astra Aktiebolag | Method for treating respiratory diseases |
WO1999049865A1 (en) * | 1998-03-31 | 1999-10-07 | Mayo Foundation For Medical Education And Research | Use of platelet activating factor (paf) inhibitors to inhibit il-5 induced eosinophil activation or degranulation |
US6172053B1 (en) | 1999-02-24 | 2001-01-09 | Ruben G. Fabunan | Injection viral treatment |
US6576224B1 (en) | 1999-07-06 | 2003-06-10 | Sinuspharma, Inc. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
WO2001028550A1 (en) * | 1999-10-15 | 2001-04-26 | Mayo Foundation For Medical Education And Research | Topical anesthetics useful for treating cancer, autoimmune diseases and ischemia |
CA2387786A1 (en) * | 1999-10-15 | 2001-04-26 | Regents Of The University Of Minnesota | Treatment of eosinophil associated pathologies by modulating pkc-.delta. activity |
CA2292902C (en) * | 1999-12-24 | 2012-12-18 | Alain Cadieux | Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases |
US20020046357A1 (en) * | 1999-12-28 | 2002-04-18 | Jiandong Huang | Software-based fault tolerant networking using a single LAN |
US6846486B1 (en) * | 2000-02-24 | 2005-01-25 | Advanced Biotherapy Concepts, Inc. | Method of treating allergy by administering an anti-histamine antibody |
CA2414389A1 (en) * | 2000-06-23 | 2002-01-03 | Mayo Foundation For Medical Education & Research | Methods of treating neutrophil-related diseases with topical anesthetics |
USRE44145E1 (en) | 2000-07-07 | 2013-04-09 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
CA2447302C (en) * | 2001-05-01 | 2008-07-29 | A.V. Topchiev Institute Of Petrochemical Synthesis | Two-phase, water-absorbent bioadhesive composition |
US8541021B2 (en) * | 2001-05-01 | 2013-09-24 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
US20050113510A1 (en) | 2001-05-01 | 2005-05-26 | Feldstein Mikhail M. | Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components |
US8206738B2 (en) * | 2001-05-01 | 2012-06-26 | Corium International, Inc. | Hydrogel compositions with an erodible backing member |
US8840918B2 (en) * | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
US20050215727A1 (en) | 2001-05-01 | 2005-09-29 | Corium | Water-absorbent adhesive compositions and associated methods of manufacture and use |
DE60233217D1 (de) | 2001-05-01 | 2009-09-17 | Corium Internat Inc | Hydrogel-zusammensetzungen |
WO2002089849A1 (en) * | 2001-05-07 | 2002-11-14 | Corium International | Compositions and delivery systems for administration of a local anesthetic agent |
US20040076671A1 (en) * | 2002-10-21 | 2004-04-22 | Aletha Tippett | Methods and compositions for topical wound treatment |
CA2507115C (en) * | 2002-11-21 | 2014-08-05 | Ira Sanders | Treatment of mammalian reaction to ige interactions |
US20050119340A1 (en) * | 2003-06-13 | 2005-06-02 | David Anderson | Treatment methods with low-dose, longer-acting formulations of local anesthetics and other agents |
EP1729724A4 (en) | 2003-12-31 | 2008-07-23 | Cydex Inc | INHALATION FORMULATION WITH SULFOALKYL ETHER GAMMA CYCLODEXTRIN AND CORTICOSTEROID |
US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
CN102764247B (zh) | 2004-01-30 | 2016-04-20 | 考里安国际公司 | 递送活性剂的快速溶解膜 |
EP1730751B1 (en) * | 2004-03-12 | 2009-10-21 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | A magnetoresistive medium |
KR20070001232A (ko) * | 2004-04-21 | 2007-01-03 | 교와 핫꼬 고교 가부시끼가이샤 | 만성 부비강염의 예방 및/또는 치료제 |
RU2393877C2 (ru) * | 2004-08-05 | 2010-07-10 | Кориум Интернэшнл, Инк. | Адгезивная композиция |
WO2006065722A2 (en) * | 2004-12-16 | 2006-06-22 | Advanced Inhalation Research, Inc. | Compositions and methods for pulmonary conditions |
US20070197486A1 (en) * | 2005-12-20 | 2007-08-23 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids |
US20070185066A1 (en) * | 2005-12-20 | 2007-08-09 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
US20070160542A1 (en) * | 2005-12-20 | 2007-07-12 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
US20070249572A1 (en) * | 2005-12-20 | 2007-10-25 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
US20070178049A1 (en) * | 2005-12-20 | 2007-08-02 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
EP1988880A2 (en) * | 2006-02-15 | 2008-11-12 | Tika Läkemedel AB | Stable mixture of corticosteroids |
WO2007136707A2 (en) * | 2006-05-17 | 2007-11-29 | University Of Utah Research Foundation | Methods and compositions related to eosinophil regulation |
WO2009006688A1 (en) * | 2007-07-11 | 2009-01-15 | Medvet Science Pty Ltd | Regulating il-4 and il- 13 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptor |
EP2387394B1 (en) | 2009-01-14 | 2018-05-02 | Corium International, Inc. | Transdermal administration of tamsulosin |
RU2446839C1 (ru) * | 2010-08-13 | 2012-04-10 | Государственное учреждение Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского (ГУ МОНИКИ им. М.Ф. Владимирского) | Способ комплексного лечения больных с воспалительными заболеваниями придаточных пазух носа |
US9636425B2 (en) * | 2012-09-18 | 2017-05-02 | Focal Point Technologies, Llc | Method of dry dye delivery for staining the eye |
US9867834B2 (en) * | 2015-06-15 | 2018-01-16 | Banner Life Sciences Llc | Non-systemic topical compositions comprising corticosteroids |
WO2016205172A1 (en) | 2015-06-15 | 2016-12-22 | Banner Life Sciences Llc | Soft lozenges comprising corticosteroids |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3385M (fr) * | 1963-12-02 | 1965-06-21 | Sobio Lab | Compositions thérapeutiques a base d'ascorbate de procaine. |
US4626530A (en) * | 1981-06-23 | 1986-12-02 | Schulte Thomas L | Treatment of eye inflammation with biphenamine |
US4466973A (en) * | 1983-02-01 | 1984-08-21 | Thomas Rennie | Method of treating nasal and sinus congestion |
US4748022A (en) * | 1985-03-25 | 1988-05-31 | Busciglio John A | Topical composition |
US5134166A (en) * | 1988-12-02 | 1992-07-28 | Genderm Corporation | Method for treating nasal disorders and headaches |
-
1993
- 1993-02-02 US US08/012,343 patent/US5510339A/en not_active Expired - Lifetime
-
1994
- 1994-01-25 CA CA002155200A patent/CA2155200C/en not_active Expired - Fee Related
- 1994-01-25 DE DE69428268T patent/DE69428268T2/de not_active Expired - Lifetime
- 1994-01-25 AT AT94907887T patent/ATE205389T1/de not_active IP Right Cessation
- 1994-01-25 PT PT94907887T patent/PT682514E/pt unknown
- 1994-01-25 JP JP6518086A patent/JPH08505157A/ja active Pending
- 1994-01-25 ES ES94907887T patent/ES2164097T3/es not_active Expired - Lifetime
- 1994-01-25 NZ NZ261990A patent/NZ261990A/xx unknown
- 1994-01-25 AU AU61282/94A patent/AU685777B2/en not_active Ceased
- 1994-01-25 DK DK94907887T patent/DK0682514T3/da active
- 1994-01-25 WO PCT/US1994/000901 patent/WO1994017790A1/en active IP Right Grant
- 1994-01-25 EP EP94907887A patent/EP0682514B1/en not_active Expired - Lifetime
-
1996
- 1996-03-20 US US08/618,860 patent/US5631267A/en not_active Expired - Lifetime
-
2001
- 2001-01-25 JP JP2001017379A patent/JP2001192334A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0682514B1 (en) | 2001-09-12 |
AU685777B2 (en) | 1998-01-29 |
NZ261990A (en) | 1997-08-22 |
JPH08505157A (ja) | 1996-06-04 |
JP2001192334A (ja) | 2001-07-17 |
US5631267A (en) | 1997-05-20 |
EP0682514A1 (en) | 1995-11-22 |
ATE205389T1 (de) | 2001-09-15 |
PT682514E (pt) | 2002-03-28 |
CA2155200C (en) | 2006-12-19 |
US5510339A (en) | 1996-04-23 |
CA2155200A1 (en) | 1994-08-18 |
WO1994017790A1 (en) | 1994-08-18 |
DK0682514T3 (da) | 2002-01-14 |
DE69428268D1 (de) | 2001-10-18 |
DE69428268T2 (de) | 2002-06-27 |
AU6128294A (en) | 1994-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2164097T3 (es) | Uso de anestesicos topicos para la fabricacion de un medicamento para el tratamiento del asma bronquial. | |
PT671910E (pt) | Utilizacao de derivados de adamantano no fabrico de um medicamento para o tratamento do glaucoma | |
ES2059965T3 (es) | Un procedimiento para preparar una composicion farmaceutica para el tratamiento de enfermedades inflamatorias. | |
DE69418601D1 (de) | Guanidinderivate mit therapeutischer wirkung | |
CA2549550A1 (en) | Botulinum toxin therapy for skin disorders | |
KR960703009A (ko) | 중추유래의 수면성 무호흡증 및 호흡곤란증의 치료를 위한 모다피닐의 사용 | |
ES2194025T3 (es) | Toxinas botulinicas multiples para tratar trastornos y enfermedades neuromusculares. | |
ES2061989T3 (es) | Uso de esteres alquilicos del acido piroglutamico para la fabricacion de un medicamento para el tratamiento de la ictiosis. | |
ES2096577T3 (es) | Utilizacion del cetoconazol y un retinoide para el tratamiento del acne vulgar. | |
ES2147788T3 (es) | 3,4-diarilcromanos para el tratamiento de la dermatitis. | |
WO2002000218A3 (en) | Methods of treating neutrophil-related diseases with topical anesthetics | |
NZ517038A (en) | Use of serotonin reuptake inihibitor in medicaments for treating sexual dysfunction | |
MXPA02006610A (es) | Sustancias para uso al tratar psoriasis. | |
ES2126123T3 (es) | Empleo de cineol o mentol para el tratamiento de asma. | |
ES2149279T3 (es) | Sistema terapeutico para el tratamiento de la psoriasis. | |
WO2004105690A3 (en) | Treatment of chronic pain associated with drug or radiation therapy | |
KR910005858A (ko) | 지방산 요법 | |
PT651654E (pt) | Utilizacao de um dimero de lisozima para a preparacao de um medicamento para modular os mecanismos natutais de defesa | |
ES2093829T3 (es) | Composicion farmaceutica para el tratamiento del asma y de las afecciones de las vias respiratorias. | |
EE200200549A (et) | Jagatud doosi teraapia veresooni kahjustava aktiivsusega | |
MX9301879A (es) | Medicamento para el tratamiento de la inflamacion de las vias respiratorias | |
DE69434002D1 (de) | 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis | |
YU107692A (sh) | Sulfonamidi i postupak za njihovo dobijanje | |
JPS5585526A (en) | Remedy for allergic disease | |
ES2124926T3 (es) | Uso de desoxipergualina para la preparacion de un medicamento para el tratamiento de enfermedades inflamatorias e hiperreactivas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 682514 Country of ref document: ES |